From: What role can decentralized trial designs play to improve rare disease studies?
Phase | Online Recruitment | Electronic Consent (Remote eConsent) | Electronic Consent (On-Site eConsent) | Electronic Patient Education + Engagement | Electronic Clinical Outcome Assessments (eCOAs) | Telehealth | Wearable Sensors | Home Health Visits by Healthcare Professionals | Drug Supply by Mail |
---|---|---|---|---|---|---|---|---|---|
Natural History Study/Registry | + | + | + | + | + | + | |||
First in Human/Ph1 | + | + | + | + | |||||
Phase II/III | + | + | + | + | + | + | + | + | |
Open Label Extension | + | + | + | + | + | + | + | ||
Post-Approval Observational | + | + | + | + | + | + | |||
Long-Term Followup | + | + | + | + | + |